JX 10
Alternative Names: BllB-131; JX-10; TMS-007Latest Information Update: 21 Feb 2025
Price :
$50 *
At a glance
- Originator TMS
- Class Anti-inflammatories; Antithrombotics; Cardiovascular therapies; Small molecules
- Mechanism of Action Fibrinolytic agents; Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Stroke